Cargando…
Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence
AIM: The safety and efficacy of nalmefene in Japanese patients with high or very high World Health Organization drinking risk level of alcohol dependence were assessed in a multicenter, randomized, double‐blind, placebo‐controlled, phase 3 (lead‐in) study. Here, the long‐term safety and efficacy of...
Autores principales: | Higuchi, Susumu, Takahashi, Masayoshi, Murai, Yoshiyuki, Tsuneyoshi, Kana, Nakamura, Izuru, Meulien, Didier, Miyata, Hisatsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496902/ https://www.ncbi.nlm.nih.gov/pubmed/32359104 http://dx.doi.org/10.1111/pcn.13017 |
Ejemplares similares
-
Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial
por: Miyata, Hisatsugu, et al.
Publicado: (2019) -
Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’
por: Higuchi, Susumu, et al.
Publicado: (2020) -
Nalmefene: a new approach to the treatment of alcohol dependence
por: Paille, François, et al.
Publicado: (2014) -
Nalmefene: a new approach to the treatment of alcohol dependence [Corrigendum]
Publicado: (2015) -
Safety and Persistence of Nalmefene Treatment for Alcohol Dependence. Results from Two Post-authorisation Safety Studies
por: Chick, Jonathan, et al.
Publicado: (2021)